PA
Perceptive Advisors’s RAPT Therapeutics RAPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.47M | Sell |
183,890
-4,235,057
| -96% | -$33.9M | 0.05% | 72 |
|
2025
Q1 | $5.39M | Sell |
4,418,947
-1,461,053
| -25% | -$1.78M | 0.19% | 64 |
|
2024
Q4 | $9.29M | Buy |
+5,880,000
| New | +$9.29M | 0.26% | 62 |
|
2024
Q2 | – | Sell |
-1,223,472
| Closed | -$11M | – | 120 |
|
2024
Q1 | $11M | Sell |
1,223,472
-916,478
| -43% | -$8.23M | 0.19% | 73 |
|
2023
Q4 | $53.2M | Buy |
2,139,950
+219,292
| +11% | +$5.45M | 1.19% | 25 |
|
2023
Q3 | $31.9M | Sell |
1,920,658
-367,835
| -16% | -$6.11M | 1.06% | 30 |
|
2023
Q2 | $42.8M | Sell |
2,288,493
-3,115
| -0.1% | -$58.3K | 1.24% | 23 |
|
2023
Q1 | $42.1M | Buy |
2,291,608
+492,653
| +27% | +$9.04M | 1.24% | 23 |
|
2022
Q4 | $35.6M | Buy |
1,798,955
+85,821
| +5% | +$1.7M | 1% | 29 |
|
2022
Q3 | $41.2M | Sell |
1,713,134
-200,657
| -10% | -$4.83M | 1.2% | 27 |
|
2022
Q2 | $34.9M | Sell |
1,913,791
-886,171
| -32% | -$16.2M | 1.09% | 23 |
|
2022
Q1 | $61.6M | Sell |
2,799,962
-127,603
| -4% | -$2.81M | 1.23% | 21 |
|
2021
Q4 | $108M | Buy |
2,927,565
+20,000
| +0.7% | +$735K | 1.66% | 16 |
|
2021
Q3 | $90.3M | Buy |
2,907,565
+431,905
| +17% | +$13.4M | 1.31% | 20 |
|
2021
Q2 | $78.7M | Sell |
2,475,660
-1,821
| -0.1% | -$57.9K | 1.02% | 28 |
|
2021
Q1 | $55M | Buy |
2,477,481
+900,000
| +57% | +$20M | 0.7% | 39 |
|
2020
Q4 | $31.2M | Buy |
+1,577,481
| New | +$31.2M | 0.33% | 62 |
|